Circulating insulin‐like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
Open Access
- 7 September 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 144 (5) , 957-966
Abstract
Insulin‐like growth factor‐I (IGF‐I) regulates cell proliferation and apoptosis, and is thought to play a role in tumour development. Previous prospective studies have shown that higher circulating concentrations of IGF‐I are associated with a higher risk of cancers at specific sites, including breast and prostate. No prospective study has examined the association between circulating IGF‐I concentrations and melanoma risk. A nested case–control study of 1,221 melanoma cases and 1,221 controls was performed in the European Prospective Investigation into Cancer and Nutrition cohort, a prospective cohort of 520,000 participants recruited from 10 European countries. Conditional logistic regression was used to estimate odds ratios (ORs) for incident melanoma in relation to circulating IGF‐I concentrations, measured by immunoassay. Analyses were conditioned on the matching factors and further adjusted for age at blood collection, education, height, BMI, smoking status, alcohol intake, marital status, physical activity and in women only, use of menopausal hormone therapy. There was no significant association between circulating IGF‐I concentration and melanoma risk (OR for highest vs lowest fifth = 0.93 [95% confidence interval [CI]: 0.71 to 1.22]). There was no significant heterogeneity in the association between IGF‐I concentrations and melanoma risk when subdivided by gender, age at blood collection, BMI, height, age at diagnosis, time between blood collection and diagnosis, or by anatomical site or histological subtype of the tumour (Pheterogeneity≥0.078). We found no evidence for an association between circulating concentrations of IGF‐I measured in adulthood and the risk of melanoma.Keywords
Funding Information
- Cancer Research UK (C570/A1649, C8221/A19170)
- Associazione Italiana per la Ricerca sul Cancro
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Cancerfonden
- Centre International de Recherche sur le Cancer
- Consiglio Nazionale delle Ricerche
- Deutsche Krebshilfe
- Deutsches Krebsforschungszentrum
- Directorate-General for Health and Food Safety
- Health Research Council of New Zealand
- Institut Gustave-Roussy
- Institut National de la Santé et de la Recherche Médicale
- Kræftens Bekæmpelse
- Kreftforeningen (6823329)
- Ligue Contre le Cancer
- Medical Research Council Canada (1000143MR/M012190/1)
- Ministerie van Volksgezondheid, Welzijn en Sport
- Mutuelle Générale de l'Education Nationale
- NordForsk
- Vetenskapsrådet
- World Cancer Research Fund
- Kreftforeningen
This publication has 23 references indexed in Scilit:
- Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanomaCancer Causes & Control, 2011
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesThe Lancet Oncology, 2010
- Insulin and insulin-like growth factor signalling in neoplasiaNature Reviews Cancer, 2008
- Case–Control Studies2008
- IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and SurvivinJournal of Investigative Dermatology, 2008
- Nonsolar occupational risk factors for cutaneous melanomaInternational Journal of Dermatology, 2008
- Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factorsEuropean Journal of Cancer, 2005
- Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposureEuropean Journal of Cancer, 2005
- Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamicsThe International Journal of Biochemistry & Cell Biology, 1996
- Assessing bias in case-control studies. Proper selection of cases and controls.Stroke, 1991